Yudong Li Selected Research

Yudong Li Research Topics

Disease

16	Neoplasms (Cancer) 04/2024 - 01/2013
10	Breast Neoplasms (Breast Cancer) 02/2024 - 11/2017
2	Foreign Bodies (Foreign Body) 04/2024 - 12/2023
2	Squamous Cell Carcinoma of Head and Neck 03/2023 - 01/2022
1	Neoplasm Metastasis (Metastasis) 04/2024
1	Cardiotoxicity 02/2024
1	Inflammation (Inflammations) 01/2023
1	Anemia 05/2022
1	Lymphoid Leukemia 01/2022
1	Chronic Renal Insufficiency 09/2021
1	Long Term Adverse Effects 06/2021
1	Papillary Thyroid Cancer 01/2021
1	Triple Negative Breast Neoplasms 03/2020
1	Wounds and Injuries (Trauma) 02/2019
1	Burns 02/2019
1	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2018
1	Infections 07/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2010
1	Birth Weight (Birth Weights) 10/2004

Drug/Important Bio-Agent (IBA)

5	Long Noncoding RNAIBA 10/2023 - 11/2017
4	Proteins (Proteins, Gene)FDA Link 10/2023 - 11/2020
2	Cyclin D1IBA 01/2023 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2017
2	Tamoxifen FDA LinkGeneric 11/2020 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2020 - 01/2018
2	Estrogen ReceptorsIBA 01/2020 - 01/2020
1	Peptides (Polypeptides)IBA 04/2024
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024
1	IntegrinsIBA 04/2024
1	1- cyclohexyl- 2- (5H- imidazo(5,1- a)isoindol- 5- yl)ethanolIBA 04/2024
1	PorphyrinsIBA 04/2024
1	Biocompatible Materials (Biomaterials)IBA 04/2024
1	1-dodecylpyridoxal (PLD)IBA 02/2024
1	pertuzumabIBA 02/2024
1	liposomal doxorubicin (Doxil)FDA Link 02/2024
1	Trastuzumab (Herceptin)FDA Link 02/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024
1	Epidermal Growth Factor (EGF)IBA 02/2024
1	AnthracyclinesIBA 02/2024
1	Taxoids (Taxanes)IBA 02/2024
1	SolutionsIBA 12/2023
1	SaltsIBA 12/2023
1	CyclinsIBA 10/2023
1	MTOR InhibitorsIBA 01/2023
1	thiamine triphosphorate (TTP)IBA 01/2023
1	OligonucleotidesIBA 01/2023
1	palbociclibIBA 01/2023
1	CarbonIBA 05/2022
1	Erythropoietin FDA Link 05/2022
1	A-factor (Streptomyces)IBA 01/2022
1	Calcium-Binding ProteinsIBA 01/2022
1	PotassiumIBA 01/2022
1	LigandsIBA 01/2022
1	Karyopherins (Importin)IBA 01/2022
1	Diacylglycerol KinaseIBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 09/2021
1	Coffee FDA Link 09/2021
1	HydrocarbonsIBA 06/2021
1	Petroleum (Crude Oil)IBA 06/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Circular RNAIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 11/2020
1	Carrier Proteins (Binding Protein)IBA 03/2020
1	Circulating Tumor DNAIBA 01/2020
1	VaccinesIBA 07/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2013
1	Neuroprotective AgentsIBA 09/2011
1	Peroxynitrous Acid (Peroxynitrite)IBA 09/2011
1	myricetinIBA 09/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2004

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2024 - 06/2010
6	Therapeutics 01/2024 - 07/2018
3	Neoadjuvant Therapy 02/2024 - 06/2018
2	Immunotherapy 04/2024 - 01/2024
2	Radiotherapy 01/2022 - 01/2018
1	Photochemotherapy (Photodynamic Therapy) 04/2024
1	Segmental Mastectomy (Lumpectomy) 02/2024
1	Combination Drug Therapy (Combination Chemotherapy) 02/2024
1	Neck Dissection (Radical Neck Dissection) 01/2022
1	Lasers (Laser) 02/2019
1	Mastectomy (Mammectomy) 08/2018
1	Prophylactic Mastectomy 08/2018
1	Tissue Transplantation 06/2010